[Update on current care guidelines: benign prostatic hyperplasia]

Duodecim. 2012;128(10):1046-7.
[Article in Finnish]

Abstract

Most benign prostatic hyperplasia (BPH) patients can be diagnosed and treated in primary care. Evaluation requires a medical history and a symptom score (DAN-PSS or IPSS) and a careful physical examination including a digital rectal examination. Careful follow-up and medical therapy are the usual first-line management options in uncomplicated BPH. Combination therapy with both alpha-blocker and 5alpha-reductase inhibitor is the most effective medical treatment modality. Transurethral resection (TURP) is a safe and effective way of treating BPH. The green laser is the most promising new endoscopic treatment modality.

Publication types

  • English Abstract
  • Review

MeSH terms

  • 5-alpha Reductase Inhibitors / therapeutic use
  • Adrenergic alpha-Antagonists / therapeutic use
  • Endoscopy
  • Humans
  • Laser Therapy
  • Male
  • Medical History Taking
  • Physical Examination
  • Practice Guidelines as Topic
  • Primary Health Care
  • Prostatic Hyperplasia / diagnosis*
  • Prostatic Hyperplasia / therapy*
  • Transurethral Resection of Prostate

Substances

  • 5-alpha Reductase Inhibitors
  • Adrenergic alpha-Antagonists